Exosome Facial: The Next Generation of Skin Rejuvenation

This article is for informational purposes only and does not constitute medical advice. Consult a board-certified dermatologist or licensed aesthetician before starting any new skin treatment.

Some links in this article may be affiliate links. See our full disclosure.

What Is an Exosome Facial?

An exosome facial is an advanced skin rejuvenation treatment that uses exosomes --- tiny extracellular vesicles naturally produced by cells --- to deliver concentrated signaling molecules directly into the skin. These nanoscale messengers (typically 30--150 nanometers in diameter) carry a cargo of growth factors, cytokines, messenger RNA, microRNA, and lipids that instruct skin cells to repair, regenerate, and produce new collagen.

Think of exosomes as the communication system between cells. When a stem cell releases exosomes, those vesicles carry instructions that tell neighboring cells how to behave --- to produce more collagen, reduce inflammation, accelerate healing, or fight oxidative stress. An exosome facial harnesses this natural signaling mechanism by applying a concentrated solution of exosomes to the skin, typically after a penetration-enhancing procedure like microneedling or radiofrequency treatment.

The exosomes used in aesthetic treatments are most commonly derived from mesenchymal stem cells (MSCs) sourced from adipose tissue, bone marrow, or umbilical cord tissue. Some newer formulations use plant-derived exosomes or platelet-derived extracellular vesicles. Regardless of the source, the underlying mechanism is the same: delivering a payload of regenerative signals that the skin's own cells can interpret and act on.

You can explore the full treatment profile, including how it compares to other rejuvenation options, on our exosome facial treatment page.

How Exosome Facials Work: The Science of Cell-to-Cell Communication

To understand why exosome facials are generating serious interest in dermatology, it helps to know what happens at the cellular level. A 2024 review published in Clinical and Experimental Dermatology described exosomes as "key mediators of intercellular communication" that regulate multiple biological processes critical to skin health (PMC).

Here is what the research tells us about the mechanisms at work:

Collagen Synthesis Stimulation Exosomes activate the TGF-beta/Smad and MAPK/AP-1 signaling pathways in dermal fibroblasts, directly stimulating the production of type I and type III collagen. A 2024 review in Biomedicines confirmed that exosome-treated tissue showed measurably increased collagen deposition and improved collagen fiber alignment compared to untreated controls (PMC).

MicroRNA Delivery Exosomes carry specific microRNA molecules --- including miR-29a, miR-125b, and miR-138-5p --- that regulate fibroblast differentiation, reduce scar-forming pathways, and promote healthy tissue remodeling. These molecules effectively reprogram aged or damaged cells to behave more like young, healthy ones.

Oxidative Stress Reduction UV damage and environmental stressors accelerate skin aging through oxidative stress. Exosomes upregulate the SIRT1/Nrf2 pathway, which protects against UV-induced damage and helps reverse signs of photoaging. A review published in the Journal of Cosmetic Dermatology (2025) documented these protective effects across multiple preclinical and clinical studies (Wiley).

Angiogenesis and Nutrient Delivery Exosomes stimulate the formation of new blood vessels (neoangiogenesis), improving blood flow and nutrient delivery to the dermis. Two of nine studies in a 2024 systematic review documented increased angiogenesis in exosome-treated skin, which supports long-term tissue health and a more vibrant complexion.

Reversal of Cellular Senescence One of the most compelling mechanisms is exosomes' ability to reverse fibroblast senescence --- essentially rejuvenating aged skin cells so they resume producing collagen and elastin at levels closer to their younger state. This is a qualitatively different mechanism from treatments that simply stimulate existing cells; exosomes may actually restore cellular function.

The delivery method matters significantly. When applied to intact skin, exosomes have limited penetration through the stratum corneum. This is why most clinical protocols pair exosome application with microneedling, fractional laser, or radiofrequency treatments that create micro-channels in the skin, allowing the exosomes to reach the deeper dermal layers where they can interact with fibroblasts and other target cells.

What the Research Shows: Clinical Evidence for Exosome Facials

The clinical evidence for exosome facials is still emerging, but several well-designed studies have produced promising --- and measurable --- results. A comprehensive 2025 systematic review in the International Journal of Molecular Sciences evaluated all available human clinical trials and found that, while study sizes remain small, the consistency of positive outcomes is notable (MDPI).

Wrinkle Reduction and Skin Elasticity

The strongest evidence for exosome facials in anti-aging comes from a 2023 split-face randomized controlled trial by Park and Kwon, published in the Journal of Cosmetic Dermatology. The study enrolled 28 participants (ages 43--66) who received three sessions of microneedling over 12 weeks, with adipose-derived stem cell exosomes applied to one side of the face and saline to the other.

The results were statistically significant:

• Wrinkle reduction: 12.4% on the exosome-treated side versus 6.6% on the control side
• Skin elasticity: Increased 11.3% on the exosome side versus a 3.3% decline on the control side (p = 0.002)
• Melanin index: Decreased 9.9% on the exosome side versus only 1.0% on the control side (p = 0.044)

A separate study by Jo et al. (2022) using bacterial-derived exosomes on 16 subjects found even more dramatic short-term improvements: 15.89% eye wrinkle reduction, 27.07% increase in skin elasticity, and 21.40% increase in skin water content at four weeks.

Skin Health and Rejuvenation

A larger study by Proffer et al. (2022) examined topical platelet-derived exosomes applied twice daily for six weeks in 56 participants (ages 40--80). The results showed a mean skin health improvement of 224.2 +/- 112.8 points on a validated scoring system (p < 0.0001). Top responders demonstrated up to 440% improvement in overall skin health parameters. Importantly, 98.2% of participants expressed willingness to continue treatment, suggesting high subjective satisfaction alongside the objective measurements.

A 2024 study by Svolacchia et al. enrolled 72 female participants (ages 34--68) who received a single intradermal injection of adipose-derived exosomes. All measured outcomes --- wrinkles, softness, hydration --- showed statistically significant improvements (p < 0.0001) that were sustained at the 90-day follow-up.

Acne Scar Treatment

Exosomes show particular promise when combined with ablative procedures for acne scarring. Kwon et al. (2020) conducted a split-face trial with 25 patients combining adipose-derived stem cell exosomes with fractional CO2 laser treatment. The exosome-treated side achieved a 32.5% improvement in ECCA (Echelle d'Evaluation Clinique des Cicatrices d'Acne) scores compared to 19.9% improvement with laser alone (p < 0.01). Post-treatment erythema also resolved faster on the exosome side (4.1 vs. 4.3 days, p = 0.03).

Sensitive Skin

For patients with reactive or sensitive skin, a study by Ye et al. (2022) tested MSC-derived exosomes applied topically twice daily for 28 days in 22 female participants. The treatment produced significant improvements in roughness, erythema, and dryness (p < 0.05), with 80% of participants rating the treatment as "very satisfactory" and no adverse events reported.

Wound Healing

While not directly an aesthetic application, exosomes' wound-healing properties underpin their rejuvenation effects. A 2022 systematic review identified 105 preclinical studies confirming that exosome therapy improved wound healing regardless of administration mode or frequency. A small human safety trial by Johnson et al. (2023) with 11 healthy adults confirmed a favorable safety profile for platelet-derived extracellular vesicle injections, with no severe adverse events.

Explore the full body of clinical evidence on our research page.

Exosome Facial vs. PRP (Vampire Facial): How They Compare

One of the most common questions patients ask is how exosome facials compare to PRP (platelet-rich plasma) treatments, commonly known as vampire facials. Both treatments aim to harness the body's regenerative mechanisms, but they take fundamentally different approaches. For a detailed side-by-side breakdown, see our exosome facial vs. vampire facial comparison.

The Head-to-Head Clinical Evidence

The most direct clinical comparison comes from a 2025 investigator-blinded, split-face trial that enrolled 15 participants (ages 44--68) with photoaging concerns. Each participant received three radiofrequency microneedling treatments at four-week intervals, with PRP applied to one side of the face and adipose mesenchymal stem cell-derived exosomes applied to the other (PMC).

The key findings:

• Both treatments achieved equivalent improvement in overall skin appearance, wrinkling, dyschromia, erythema, and texture
• Baseline Griffiths Photonumeric Photoaging Scale scores improved 37% at three months and 22% at six months for both treatments
• The exosome-treated side showed slightly greater improvements in wrinkling, erythema, and texture, though the difference was not statistically significant
• Histological analysis of 74 biopsy samples from 10 participants confirmed significant increases in collagen I and glycosaminoglycans for both treatments, with no statistically significant differences between the two

The researchers concluded that "ASC exosomes are a promising PRP-alternative" for skin rejuvenation.

Practical Differences

Beyond raw efficacy, several practical considerations separate the two treatments:

Which Should You Choose?

PRP remains the more established option with a longer research track record and the advantage of using your own biological material, which eliminates concerns about sourcing and contamination. It is a well-understood treatment that consistently delivers results.

Exosome facials offer practical advantages --- no blood draw, faster preparation, and potentially fewer sessions needed --- but come with significant caveats around the lack of FDA approval and product standardization. The quality of exosome products varies substantially between manufacturers, and there is currently no regulatory framework ensuring consistency.

For patients who are needle-averse or uncomfortable with blood draws, exosomes offer a more comfortable experience. For those who prioritize an established safety record and regulatory clarity, PRP may be the more prudent choice. Many forward-thinking clinics now offer both options and can help determine which approach is best suited to your specific skin concerns.

What to Expect During an Exosome Facial

Understanding the treatment process can help you prepare and set realistic expectations. Here is a typical exosome facial protocol, though individual providers may vary their approach.

Before Your Appointment

Most providers will ask you to:

• Discontinue retinoids 3--5 days before treatment
• Avoid blood-thinning supplements (fish oil, vitamin E, aspirin) for one week prior
• Arrive with clean skin --- no makeup, sunscreen, or heavy moisturizers
• Complete a consultation where the provider assesses your skin, discusses goals, and reviews your medical history

During the Treatment (45--90 minutes)

Step 1: Cleansing and Assessment (10 minutes) Your provider thoroughly cleanses the skin and may take baseline photographs for tracking progress.

Step 2: Penetration Enhancement (20--40 minutes) Most protocols begin with a microneedling session, radiofrequency microneedling, or a light fractional laser treatment. This step serves two purposes: it triggers the skin's own wound-healing response and creates micro-channels that allow the exosomes to penetrate deep into the dermis. The depth and intensity are customized to your skin type and concerns.

Step 3: Exosome Application (10--15 minutes) The exosome solution is applied topically to the treated skin, either during or immediately after the microneedling procedure. The micro-channels created in the previous step allow the exosomes to bypass the stratum corneum and reach the deeper dermal layers. Some providers use a gentle massage or specialized applicator to ensure even distribution.

Step 4: Post-Treatment Soothing (5--10 minutes) A calming mask or hydrating serum may be applied to reduce immediate redness and sensitivity.

After Your Treatment

Recovery from an exosome facial is typically mild:

• Days 1--2: Expect mild redness, warmth, and slight swelling similar to a moderate sunburn. These effects are primarily from the microneedling component.
• Days 3--5: Redness fades. You may notice mild flaking or dryness as the skin turns over.
• Days 7--14: Skin begins to look noticeably brighter, smoother, and more hydrated.
• Weeks 4--12: Progressive improvement in fine lines, texture, and tone as new collagen matures.
• Months 3--6: Full results become apparent as collagen remodeling completes.

Most protocols recommend a series of 3--6 sessions spaced 2--4 weeks apart for optimal results, followed by maintenance treatments every 3--6 months.

How Much Does an Exosome Facial Cost?

Exosome facial pricing varies significantly based on geographic location, provider credentials, the specific exosome product used, and whether the treatment includes microneedling or other complementary procedures.

National Price Ranges (2025--2026)

• Basic exosome facial (topical application only): $250--$500
• Exosome facial with microneedling: $500--$1,500 per session
• Exosome facial with RF microneedling: $800--$2,500 per session
• Full treatment course (4--6 sessions): $2,000--$9,000

Cost by Location

Pricing varies considerably by market:

• New York City: $700--$1,050 per session --- explore exosome facial providers in New York
• Los Angeles and major California metros: $600--$1,200 per session
• Mid-size cities: $400--$800 per session
• South Korea (a popular destination for exosome treatments): $500--$1,200 per session

Factors That Influence Price

Several variables affect what you will pay:

• Provider credentials: Board-certified dermatologists and plastic surgeons typically charge more than estheticians or nurse practitioners
• Exosome product quality: Products vary widely in concentration (from 5 x 10^9 to 9.78 x 10^10 particles per mL) and source tissue, which directly affects pricing
• Combination treatments: Adding microneedling, LED therapy, or radiofrequency increases the total cost but may improve outcomes
• Geographic market: Major metropolitan areas with high overhead and strong demand command premium prices

Is It Worth the Investment?

Exosome facials sit in the premium tier of non-surgical rejuvenation treatments. Compared to a standard microneedling session ($200--$800), you are paying a significant premium for the exosome component. Whether that premium delivers proportionally better results depends on the quality of the product, the skill of the provider, and your specific skin concerns.

The clinical data suggests that exosomes do enhance the results of microneedling (12.4% wrinkle reduction with exosomes vs. 6.6% without), but the absolute difference is modest. For patients with significant photoaging, acne scarring, or skin quality concerns, the added benefit may justify the cost. For mild concerns, standard microneedling or a PRP facial may deliver comparable results at a lower price point.

Use our treatment finder quiz to see which rejuvenation approach best matches your skin goals and budget.

Safety, Side Effects, and FDA Regulation

Safety is perhaps the most important consideration with exosome facials, and it is an area where patients need to be well-informed. The regulatory landscape for exosomes is complex and, in some cases, concerning.

FDA Regulatory Status

The FDA has been unambiguous: no exosome products are currently approved for cosmetic or therapeutic use in humans. The agency's December 2019 Public Safety Notification stated plainly that "exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products" under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act, requiring premarket review and approval (FDA).

This notification was prompted by serious adverse events in Nebraska patients who received unapproved exosome injections, including bacterial infections. Since then, the FDA has issued multiple warning letters to companies marketing unapproved exosome products and has continued enforcement actions into 2025.

A critical nuance: many clinics market exosome serums as being "for topical cosmetic use only," which sounds like it would fall outside FDA jurisdiction. However, as legal analysis has clarified, applying unapproved biological products onto skin that has been broken by microneedling or laser treatment constitutes administration of that product --- not simple topical application --- and falls squarely under FDA regulation.

Known Side Effects

When administered by qualified providers using properly manufactured products, the clinical literature reports a favorable safety profile:

• Common (expected and temporary): Mild redness, swelling, warmth, and sensitivity at the treatment site, typically resolving within 24--72 hours. These effects are primarily attributable to the microneedling component.
• Uncommon: Mild dryness reported in 16.1% of participants in one study (Proffer et al., 2022), likely exacerbated by seasonal conditions. Transient inflammation noted in some studies, resolving within 72 hours.
• Rare but serious (primarily associated with unregulated products): Bacterial infections, excessive inflammatory response, and theoretical risk of promoting malignancy (noted as a safety concern in systematic reviews, though not observed in published trials).

No severe adverse events were reported in any of the published controlled clinical trials reviewed for this article.

What Patients Should Know

The challenge is not whether exosomes can be safe --- the published trial data suggests they can be --- but whether the specific product your provider uses is safe. A 2024 review in Biomedical Journal highlighted that "product heterogeneity, rapid systemic clearance, and long-term stability" remain critical challenges, and that standardization of doses, administration routes, and source materials is still lacking (PMC).

Before booking an exosome facial, the FDA recommends patients:

1. Ask your provider which specific exosome product they use and where it is manufactured
2. Request documentation about the product's testing, sterility assurance, and characterization
3. Verify your provider's credentials --- board-certified dermatologists and plastic surgeons are best positioned to evaluate product quality and manage complications
4. Understand the risks --- you are receiving an unapproved biological product, and the long-term safety profile is not fully established
5. Report any adverse events to the FDA's MedWatch program

Who Should Avoid Exosome Facials

Exosome facials are generally not recommended for:

• Pregnant or breastfeeding women (insufficient safety data)
• Patients with active skin infections, open wounds, or severe acne at the treatment site
• Individuals with a history of keloid scarring (the microneedling component poses risk)
• Patients with autoimmune conditions or those on immunosuppressive therapy (theoretical concern about immune modulation)
• Anyone with a history of cancer or active malignancy (exosomes' growth-promoting properties raise theoretical concerns)

Who Is the Ideal Candidate for an Exosome Facial?

Exosome facials are best suited for patients who meet the following profile:

Best Candidates

• Ages 35--65 with early to moderate signs of photoaging (fine lines, uneven texture, loss of elasticity)
• Patients with acne scarring who want to enhance the results of microneedling or fractional laser treatments
• Those seeking non-surgical rejuvenation without the downtime of ablative procedures
• Patients with dull, dehydrated skin looking for a significant boost in radiance and hydration
• Individuals uncomfortable with blood draws who want the benefits of regenerative treatment without PRP's phlebotomy requirement
• Patients with hyperpigmentation or melasma --- clinical data shows measurable melanin reduction

Less Ideal Candidates

• Patients with mild concerns only --- standard microneedling or chemical peels may deliver sufficient results at lower cost
• Those seeking dramatic, immediate results --- exosome facials produce gradual, progressive improvement over months
• Budget-conscious patients --- the premium over standard microneedling may not be justified for all skin types and concerns
• Anyone unwilling to accept the regulatory uncertainty around unapproved biological products

The Future of Exosome Facials

The exosome facial field is evolving rapidly. Several developments are worth watching:

Standardization Efforts The International Society for Extracellular Vesicles (ISEV) has published guidelines (MISEV) for characterizing exosome products, and the dermatology community is pushing for standardized protocols that would make clinical comparisons more meaningful. As manufacturing standards improve, product consistency --- and by extension, treatment reliability --- should follow.

Engineered Exosomes Researchers are developing exosomes that have been engineered to carry specific cargo --- particular microRNAs or growth factors targeted at specific skin concerns. This precision approach could lead to customized exosome treatments for wrinkles, hyperpigmentation, scarring, or rosacea.

Plant-Derived Alternatives Several companies are exploring plant-derived exosomes (from sources like ginger, aloe, and grape) as a more sustainable and potentially more affordable alternative to stem cell-derived exosomes. Early preclinical data shows promise, though human clinical trials are still needed.

Regulatory Pathways Multiple companies are pursuing FDA approval through the biologics license application (BLA) pathway. If successful, this would provide the regulatory clarity that the field currently lacks and could significantly expand both provider and patient confidence.

Combination Protocols Clinicians are developing more sophisticated protocols that combine exosomes with specific microneedling depths, radiofrequency energy levels, and complementary serums. As these protocols are refined through clinical experience and formal studies, outcomes should continue to improve.

Frequently Asked Questions

How long do exosome facial results last?

Based on available clinical data, the collagen-stimulating effects of an exosome facial continue to develop for 3--6 months after treatment, with peak results typically visible around month three. A 2024 study by Svolacchia et al. demonstrated that improvements in wrinkles, hydration, and skin softness remained statistically significant at 90 days after a single intradermal exosome session. However, the skin continues to age after treatment, so most providers recommend maintenance sessions every 3--6 months to sustain results. The longevity of your results will depend on factors including sun exposure habits, skincare routine, age, and overall skin health. Patients who combine exosome facials with consistent sun protection and a retinoid-based home care regimen tend to maintain results longer.

Are exosome facials FDA-approved?

No. As of early 2026, no exosome products have received FDA approval for any cosmetic or therapeutic use. The FDA classifies exosomes used in human treatments as drugs and biological products that require premarket approval. The agency issued a public safety notification in December 2019 after serious adverse events were reported in Nebraska patients treated with unapproved exosome products, and has since issued multiple warning letters to manufacturers and clinics. This does not mean exosome facials are inherently dangerous --- the published clinical trial data shows a favorable safety profile --- but it does mean the products used are unregulated, and quality varies significantly between manufacturers. Always ask your provider about the specific product they use, its sourcing, and its testing protocols.

How many exosome facial sessions do I need to see results?

Most clinical protocols in the published literature use 3--6 sessions spaced 2--4 weeks apart. However, some patients report noticeable improvement after a single session. The study by Proffer et al. (2022) showed significant skin health improvements after just six weeks of twice-daily topical exosome application, while Park and Kwon (2023) documented measurable wrinkle reduction and elasticity improvements after three microneedling-plus-exosome sessions over 12 weeks. Your provider will recommend a treatment plan based on your specific concerns, skin condition, and goals. More significant concerns (deep wrinkles, pronounced scarring, extensive photodamage) typically require more sessions, while patients seeking general rejuvenation and brightening may see satisfactory results with fewer treatments.

Can I combine exosome facials with other treatments?

Yes, and in fact, the clinical evidence suggests that exosomes work best when combined with procedures that enhance skin penetration. The strongest clinical results have been achieved when exosomes are paired with microneedling (Park & Kwon, 2023; Kwon et al., 2020), fractional CO2 laser, or radiofrequency microneedling. The micro-channels created by these procedures allow exosomes to reach the deeper dermal layers where they interact with fibroblasts. Some providers also combine exosome facials with LED light therapy, chemical peels, or hyaluronic acid serums for complementary benefits. However, combining too many active treatments in a single session can increase inflammation and downtime, so work with your provider to develop an appropriate protocol.

What is the difference between exosome serum and an exosome facial treatment?

This is an important distinction. Over-the-counter exosome serums are topical products designed for daily home use. They are applied to intact skin and rely on the exosomes penetrating through the stratum corneum, which is a significant barrier. An exosome facial treatment, performed in a clinical setting, applies a higher concentration of exosomes to skin that has been prepared through microneedling or another penetration-enhancing procedure, allowing far greater absorption into the dermis. The clinical studies showing significant wrinkle reduction, elasticity improvement, and collagen stimulation all used professional-grade exosome application after microneedling --- not simple topical application to intact skin. Home-use serums may provide mild hydration and antioxidant benefits, but should not be expected to deliver the same results as a professional treatment.

The Bottom Line

Exosome facials represent a genuinely novel approach to skin rejuvenation --- one rooted in the emerging science of intercellular communication rather than simple mechanical stimulation or chemical exfoliation. The clinical evidence, while still early, is consistent and encouraging: measurable improvements in wrinkles, elasticity, hydration, pigmentation, and scarring across multiple well-designed studies.

But this is a treatment that demands informed decision-making. The absence of FDA approval, the variability in product quality, and the relatively small body of long-term safety data mean that choosing the right provider matters enormously. A board-certified dermatologist or plastic surgeon who can speak knowledgeably about the specific exosome product they use, its sourcing, and its characterization is your best safeguard.

For patients with moderate photoaging, acne scarring, or skin quality concerns who want to go beyond what standard microneedling alone can achieve --- and who are comfortable with the current regulatory landscape --- exosome facials offer a compelling option. For those who prefer to wait for regulatory clarity, PRP facials deliver comparable results with a more established safety record.

The next few years will be pivotal. As manufacturing standards improve, regulatory pathways mature, and larger clinical trials report results, the picture will become much clearer. For now, exosome facials sit at the frontier of aesthetic dermatology --- promising, measurable, and worthy of serious consideration, but requiring the kind of careful due diligence that any frontier treatment demands.

References

1. Park, G.H. & Kwon, T.R. (2023). Adipose-derived stem cell exosomes combined with microneedling for facial rejuvenation: A randomized, split-face trial. Journal of Cosmetic Dermatology. PMC

2. Shah, S. et al. (2025). Exosomes for Aesthetic Dermatology: A Comprehensive Literature Review and Update. Journal of Cosmetic Dermatology, 24, e16766. Wiley

3. Gutierrez-Fernandez, A. et al. (2025). Effectiveness of Extracellular Vesicle Application in Skin Aging Treatment and Regeneration: Do We Have Enough Evidence from Clinical Trials? International Journal of Molecular Sciences, 26(5), 2354. MDPI

4. Nkosi, D. et al. (2025). Adipose Mesenchymal Stem Cell-Derived Exosomes Versus Platelet-Rich Plasma Treatment for Photoaged Facial Skin: An Investigator-Blinded, Split-Face, Non-Inferiority Trial. Aesthetic Surgery Journal. PMC

5. Sadeghi, S. et al. (2024). Exploring the reality of exosomes in dermatology. Clinical and Experimental Dermatology. PMC

6. Huang, Y. et al. (2024). The Innovative and Evolving Landscape of Topical Exosome and Peptide Therapies: A Systematic Review of the Available Literature. Biomedicines, 12(4). PMC

7. U.S. Food and Drug Administration (2019). Public Safety Notification on Exosome Products. FDA.gov

8. Chen, J. et al. (2024). Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Biomedical Journal. PMC

9. Proffer, S.L. et al. (2022). Platelet-derived extracellular vesicles for topical skin rejuvenation: A prospective clinical study. Journal of Cosmetic Dermatology.

10. Kwon, T.R. et al. (2020). Adipose-derived stem cell exosomes combined with fractional CO2 laser for acne scars: A split-face study. Journal of Cosmetic Dermatology.

Related Reading

• Vampire Facial and PRP: What the Science Actually Shows
• Microneedling: How It Works, Results, Cost and What to Expect
• Find Your Treatment: Personalized Skin Rejuvenation Quiz

-- The SpaLens Team